Searching News Database: vagus nerve
HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
HSMN NewsFeed - 17 Aug 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
HSMN NewsFeed - 10 May 2018
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
HSMN NewsFeed - 27 Sep 2016
EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
HSMN NewsFeed - 29 Mar 2016
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
HSMN NewsFeed - 13 Jan 2016
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
HSMN NewsFeed - 2 Nov 2015
EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
HSMN NewsFeed - 9 Oct 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
HSMN NewsFeed - 9 Oct 2013
electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
HSMN NewsFeed - 12 Nov 2012
Sorin Group Announces the Acquisition of Neurotech, a Development-Stage Company Focused on Neurostimulation
Sorin Group Announces the Acquisition of Neurotech, a Development-Stage Company Focused on Neurostimulation
HSMN NewsFeed - 7 Jun 2012
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
HSMN NewsFeed - 3 Jan 2012
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
HSMN NewsFeed - 31 Oct 2011
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
HSMN NewsFeed - 24 Oct 2011
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
HSMN NewsFeed - 10 Oct 2011
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
HSMN NewsFeed - 26 Apr 2011
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
HSMN NewsFeed - 1 Feb 2011
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
HSMN NewsFeed - 22 Feb 2010
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
HSMN NewsFeed - 16 Sep 2009
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
HSMN NewsFeed - 7 Jan 2008
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
HSMN NewsFeed - 20 Aug 2007
New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
HSMN NewsFeed - 18 Jul 2006
Cyberonics Receives FDA Real-Time Review Approval for New VNS Therapy Perennia Lead
Cyberonics Receives FDA Real-Time Review Approval for New VNS Therapy Perennia Lead
Additional items found! 52
Members Archive contains
52 additional stories matching:
vagus nerve
(Password required)
vagus nerve
(Password required)